Medical Devices

Global Neuropeptide Y Receptor Market Insights, Forecast to 2025

  • QYR2792334
  • 117 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
Neuropeptide Y (NPY) receptors are involved in different types of biological processes. It is a class of G-Protein coupled receptors sensitive to closely associated peptide hormones such as peptide YY, pancreatic polypeptide, and neuropeptide Y. NPY is closely related to central mechanism involving obesity and food intake; however the topic is still a part of extensive medical research.

Increase in prevalence of various diseases related to obesity and surge in overweight populace drives the market.

Moreover, unhealthy urban lifestyle and increase in number of fast food eating populace susceptible to sudden weight gain, is expected to boost the market growth.

However, number of limited manufacturers and distribution channels is anticipated to impede the market growth.

The global Neuropeptide Y Receptor market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Neuropeptide Y Receptor market based on company, product type, end user and key regions.

This report studies the global market size of Neuropeptide Y Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neuropeptide Y Receptor in these regions.

This research report categorizes the global Neuropeptide Y Receptor market by top players/brands, region, type and end user. This report also studies the global Neuropeptide Y Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Gila Therapeutics

Novo Nordisk

XL-protein

Lilly Eli

Novartis

Pfizer

Merck & Co

Mannkind

Gilead Sciences

Genentech

Market size by Product

Food Grade

Pharmaceutical Grade

Market size by End User

Medicine

Food Additives

Others

Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Neuropeptide Y Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.

To understand the structure of Neuropeptide Y Receptor market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Neuropeptide Y Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Neuropeptide Y Receptor submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Neuropeptide Y Receptor are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neuropeptide Y Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Neuropeptide Y Receptor Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Product

1.4.2 Food Grade

1.4.3 Pharmaceutical Grade

1.5 Market by End User

1.5.1 Global Neuropeptide Y Receptor Market Size Growth Rate by End User

1.5.2 Medicine

1.5.3 Food Additives

1.5.4 Others

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Neuropeptide Y Receptor Market Size

2.1.1 Global Neuropeptide Y Receptor Revenue 2013-2025

2.1.2 Global Neuropeptide Y Receptor Sales 2013-2025

2.2 Neuropeptide Y Receptor Growth Rate by Regions

2.2.1 Global Neuropeptide Y Receptor Sales by Regions

2.2.2 Global Neuropeptide Y Receptor Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Neuropeptide Y Receptor Sales by Manufacturers

3.1.1 Neuropeptide Y Receptor Sales by Manufacturers

3.1.2 Neuropeptide Y Receptor Sales Market Share by Manufacturers

3.1.3 Global Neuropeptide Y Receptor Market Concentration Ratio (CR5 and HHI)

3.2 Neuropeptide Y Receptor Revenue by Manufacturers

3.2.1 Neuropeptide Y Receptor Revenue by Manufacturers (2013-2018)

3.2.2 Neuropeptide Y Receptor Revenue Share by Manufacturers (2013-2018)

3.3 Neuropeptide Y Receptor Price by Manufacturers

3.4 Neuropeptide Y Receptor Manufacturing Base Distribution, Product Types

3.4.1 Neuropeptide Y Receptor Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Neuropeptide Y Receptor Product Type

3.4.3 Date of International Manufacturers Enter into Neuropeptide Y Receptor Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Neuropeptide Y Receptor Sales by Product

4.2 Global Neuropeptide Y Receptor Revenue by Product

4.3 Neuropeptide Y Receptor Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Neuropeptide Y Receptor Breakdown Data by End User

6 North America

6.1 North America Neuropeptide Y Receptor by Countries

6.1.1 North America Neuropeptide Y Receptor Sales by Countries

6.1.2 North America Neuropeptide Y Receptor Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Neuropeptide Y Receptor by Product

6.3 North America Neuropeptide Y Receptor by End User

7 Europe

7.1 Europe Neuropeptide Y Receptor by Countries

7.1.1 Europe Neuropeptide Y Receptor Sales by Countries

7.1.2 Europe Neuropeptide Y Receptor Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Neuropeptide Y Receptor by Product

7.3 Europe Neuropeptide Y Receptor by End User

8 Asia Pacific

8.1 Asia Pacific Neuropeptide Y Receptor by Countries

8.1.1 Asia Pacific Neuropeptide Y Receptor Sales by Countries

8.1.2 Asia Pacific Neuropeptide Y Receptor Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Neuropeptide Y Receptor by Product

8.3 Asia Pacific Neuropeptide Y Receptor by End User

9 Central & South America

9.1 Central & South America Neuropeptide Y Receptor by Countries

9.1.1 Central & South America Neuropeptide Y Receptor Sales by Countries

9.1.2 Central & South America Neuropeptide Y Receptor Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Neuropeptide Y Receptor by Product

9.3 Central & South America Neuropeptide Y Receptor by End User

10 Middle East and Africa

10.1 Middle East and Africa Neuropeptide Y Receptor by Countries

10.1.1 Middle East and Africa Neuropeptide Y Receptor Sales by Countries

10.1.2 Middle East and Africa Neuropeptide Y Receptor Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Neuropeptide Y Receptor by Product

10.3 Middle East and Africa Neuropeptide Y Receptor by End User

11 Company Profiles

11.1 Gila Therapeutics

11.1.1 Gila Therapeutics Company Details

11.1.2 Company Business Overview

11.1.3 Gila Therapeutics Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.1.4 Gila Therapeutics Neuropeptide Y Receptor Products Offered

11.1.5 Gila Therapeutics Recent Development

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Details

11.2.2 Company Business Overview

11.2.3 Novo Nordisk Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.2.4 Novo Nordisk Neuropeptide Y Receptor Products Offered

11.2.5 Novo Nordisk Recent Development

11.3 XL-protein

11.3.1 XL-protein Company Details

11.3.2 Company Business Overview

11.3.XL-protein Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.3.4 XL-protein Neuropeptide Y Receptor Products Offered

11.3.5 XL-protein Recent Development

11.4 Lilly Eli

11.4.1 Lilly Eli Company Details

11.4.2 Company Business Overview

11.4.3 Lilly Eli Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.4.4 Lilly Eli Neuropeptide Y Receptor Products Offered

11.4.5 Lilly Eli Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Company Business Overview

11.5.3 Novartis Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.5.4 Novartis Neuropeptide Y Receptor Products Offered

11.5.5 Novartis Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Company Business Overview

11.6.3 Pfizer Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.6.4 Pfizer Neuropeptide Y Receptor Products Offered

11.6.5 Pfizer Recent Development

11.7 Merck & Co

11.7.1 Merck & Co Company Details

11.7.2 Company Business Overview

11.7.3 Merck & Co Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.7.4 Merck & Co Neuropeptide Y Receptor Products Offered

11.7.5 Merck & Co Recent Development

11.8 Mannkind

11.8.1 Mannkind Company Details

11.8.2 Company Business Overview

11.8.3 Mannkind Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.8.4 Mannkind Neuropeptide Y Receptor Products Offered

11.8.5 Mannkind Recent Development

11.9 Gilead Sciences

11.9.1 Gilead Sciences Company Details

11.9.2 Company Business Overview

11.9.3 Gilead Sciences Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.9.4 Gilead Sciences Neuropeptide Y Receptor Products Offered

11.9.5 Gilead Sciences Recent Development

11.10 Genentech

11.10.1 Genentech Company Details

11.10.2 Company Business Overview

11.10.3 Genentech Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)

11.10.4 Genentech Neuropeptide Y Receptor Products Offered

11.10.5 Genentech Recent Development

12 Future Forecast

12.1 Neuropeptide Y Receptor Market Forecast by Regions

12.1.1 Global Neuropeptide Y Receptor Sales Forecast by Regions 2018-2025

12.1.2 Global Neuropeptide Y Receptor Revenue Forecast by Regions 2018-2025

12.2 Neuropeptide Y Receptor Market Forecast by Product

12.2.1 Global Neuropeptide Y Receptor Sales Forecast by Product 2018-2025

12.2.2 Global Neuropeptide Y Receptor Revenue Forecast by Product 2018-2025

12.3 Neuropeptide Y Receptor Market Forecast by End User

12.4 North America Neuropeptide Y Receptor Forecast

12.5 Europe Neuropeptide Y Receptor Forecast

12.6 Asia Pacific Neuropeptide Y Receptor Forecast

12.7 Central & South America Neuropeptide Y Receptor Forecast

12.8 Middle East and Africa Neuropeptide Y Receptor Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Neuropeptide Y Receptor Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables and Figures

Figure Neuropeptide Y Receptor Product Picture

Table Neuropeptide Y Receptor Market Segments

Table Key Manufacturers Neuropeptide Y Receptor Covered

Table Global Neuropeptide Y Receptor Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)

Figure Global Neuropeptide Y Receptor Sales Market Share by Product 2013-2025

Figure Food Grade Product Picture

Table Major Manufacturers of Food Grade

Figure Pharmaceutical Grade Product Picture

Table Major Manufacturers of Pharmaceutical Grade

Table Global Neuropeptide Y Receptor Market Size Growth Rate by End User 2018-2025 (K Units)

Figure Medicine

Figure Food Additives

Figure Others

Figure Neuropeptide Y Receptor Report Years Considered

Figure Global Neuropeptide Y Receptor Market Size 2013-2025 (Million US$)

Figure Global Neuropeptide Y Receptor Sales 2013-2025 (K Units)

Table Global Neuropeptide Y Receptor Market Size by Regions 2013-2018 (K Units) & (Million US$)

Table Global Neuropeptide Y Receptor Sales by Regions 2013-2018 (K Units)

Table Global Neuropeptide Y Receptor Sales Market Share by Regions 2013-2018

Figure Global Neuropeptide Y Receptor Sales Market Share by Regions 2013-2018

Figure 2017 Global Neuropeptide Y Receptor Sales Market Share by Regions

Table Global Neuropeptide Y Receptor Revenue by Regions 2013-2018 (Million US$)

Table Global Neuropeptide Y Receptor Revenue Market Share by Regions 2013-2018

Figure Global Neuropeptide Y Receptor Revenue Market Share by Regions 2013-2018

Figure 2017 Global Neuropeptide Y Receptor Revenue Market Share by Regions

Table Global Neuropeptide Y Receptor Sales by Manufacturers (2013-2018) (K Units)

Table Global Neuropeptide Y Receptor Sales Share by Manufacturers (2013-2018)

Figure Global Neuropeptide Y Receptor Sales Share by Manufacturers in 2017

Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Neuropeptide Y Receptor Revenue by Manufacturers (2013-2018) (Million USD)

Table Neuropeptide Y Receptor Revenue Share by Manufacturers (2013-2018)

Figure Neuropeptide Y Receptor Value Share by Manufacturers in 2017

Table Key Manufacturers Neuropeptide Y Receptor Price (2013-2018) (USD/Unit)

Table Neuropeptide Y Receptor Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Neuropeptide Y Receptor Product Type

Table Date of International Manufacturers Enter into Neuropeptide Y Receptor Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)

Table Global Neuropeptide Y Receptor Sales Share by Product (2013-2018)

Figure Global Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)

Figure Global Neuropeptide Y Receptor Sales Market Share by Product in 2017

Table Global Neuropeptide Y Receptor Revenue by Product (2013-2018) (Million US$)

Table Global Neuropeptide Y Receptor Revenue Share by Product (2013-2018)

Figure Global Neuropeptide Y Receptor Revenue Market Share by Product (2013-2018)

Figure Global Neuropeptide Y Receptor Revenue Market Share by Product in 2017

Table Neuropeptide Y Receptor Price by Product 2013-2018 (USD/Unit)

Table Global Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)

Table Global Neuropeptide Y Receptor Sales Share by End User (2013-2018)

Figure Global Sales Neuropeptide Y Receptor Market Share by End User (2013-2018)

Figure Global Sales Neuropeptide Y Receptor Market Share by End User in 2017

Figure North America Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)

Figure North America Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)

Table North America Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)

Table North America Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)

Figure 2017 North America Neuropeptide Y Receptor Sales Market Share by Countries

Table North America Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)

Table North America Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)

Figure 2017 North America Neuropeptide Y Receptor Revenue Market Share by Countries

Figure United States Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure United States Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (K Units)

Figure Canada Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Canada Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Mexico Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Mexico Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Table North America Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)

Table North America Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)

Figure 2017 North America Neuropeptide Y Receptor Market Share by Product

Table North America Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)

Table North America Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)

Figure 2017 North America Neuropeptide Y Receptor Market Share by End User

Figure Europe Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)

Figure Europe Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)

Table Europe Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)

Table Europe Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)

Figure 2017 Europe Neuropeptide Y Receptor Sales Market Share by Countries

Table Europe Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)

Table Europe Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)

Figure 2017 Europe Neuropeptide Y Receptor Revenue Market Share by Countries

Figure Germany Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Germany Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure France Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure France Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure UK Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure UK Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Italy Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Italy Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Russia Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Russia Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Table Europe Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)

Table Europe Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)

Figure 2017 Europe Neuropeptide Y Receptor Market Share by Product

Table Europe Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)

Table Europe Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)

Figure 2017 Europe Neuropeptide Y Receptor Market Share by End User

Figure Asia Pacific Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)

Figure Asia Pacific Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)

Table Asia Pacific Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)

Table Asia Pacific Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)

Figure 2017 Asia Pacific Neuropeptide Y Receptor Sales Market Share by Countries

Table Asia Pacific Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)

Table Asia Pacific Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)

Figure 2017 Asia Pacific Neuropeptide Y Receptor Revenue Market Share by Countries

Figure China Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure China Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Japan Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Japan Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Korea Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Korea Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure India Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure India Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Australia Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Australia Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Indonesia Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Indonesia Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Malaysia Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Malaysia Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Philippines Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Philippines Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Thailand Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Thailand Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Vietnam Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Vietnam Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Singapore Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Singapore Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Table Asia Pacific Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)

Table Asia Pacific Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)

Figure 2017 Asia Pacific Neuropeptide Y Receptor Market Share by Product

Table Asia Pacific Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)

Table Asia Pacific Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)

Figure 2017 Asia Pacific Neuropeptide Y Receptor Market Share by End User

Figure Central & South America Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)

Figure Central & South America Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)

Table Central & South America Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)

Table Central & South America Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)

Figure 2017 Central & South America Neuropeptide Y Receptor Sales Market Share by Countries

Table Central & South America Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)

Table Central & South America Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)

Figure 2017 Central & South America Neuropeptide Y Receptor Revenue Market Share by Countries

Figure Brazil Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Brazil Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Argentina Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Argentina Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Table Central & South America Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)

Table Central & South America Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)

Figure 2017 Central & South America Neuropeptide Y Receptor Market Share by Product

Table Central & South America Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)

Table Central & South America Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)

Figure 2017 Central & South America Neuropeptide Y Receptor Market Share by End User

Figure Middle East and Africa Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)

Figure Middle East and Africa Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)

Table Middle East and Africa Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)

Table Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)

Figure 2017 Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Countries

Table Middle East and Africa Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)

Table Middle East and Africa Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)

Figure 2017 Middle East and Africa Neuropeptide Y Receptor Revenue Market Share by Countries

Figure GCC Countries Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure GCC Countries Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Turkey Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Turkey Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure Egypt Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure Egypt Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Figure South Africa Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)

Figure South Africa Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)

Table Middle East and Africa Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)

Table Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)

Figure 2017 Middle East and Africa Neuropeptide Y Receptor Market Share by Product

Table Middle East and Africa Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)

Table Middle East and Africa Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)

Figure 2017 Middle East and Africa Neuropeptide Y Receptor Market Share by End User

Table Gila Therapeutics Company Details

Table Gila Therapeutics Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Gila Therapeutics Recent Development

Table Novo Nordisk Company Details

Table Novo Nordisk Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Novo Nordisk Recent Development

Table XL-protein Company Details

Table XL-protein Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table XL-protein Recent Development

Table Lilly Eli Company Details

Table Lilly Eli Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Lilly Eli Recent Development

Table Novartis Company Details

Table Novartis Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Novartis Recent Development

Table Pfizer Company Details

Table Pfizer Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Pfizer Recent Development

Table Merck & Co Company Details

Table Merck & Co Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Merck & Co Recent Development

Table Mannkind Company Details

Table Mannkind Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Mannkind Recent Development

Table Gilead Sciences Company Details

Table Gilead Sciences Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Gilead Sciences Recent Development

Table Genentech Company Details

Table Genentech Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Genentech Recent Development

Table Global Neuropeptide Y Receptor Sales Forecast by Regions 2018-2025 (K Units)

Table Global Neuropeptide Y Receptor Sales Market Share Forecast by Regions 2018-2025

Table Global Neuropeptide Y Receptor Revenue Forecast by Regions 2018-2025 (Million US$)

Table Global Neuropeptide Y Receptor Revenue Market Share Forecast by Regions 2018-2025

Table Global Neuropeptide Y Receptor Sales Forecast by Product 2018-2025 (K Units)

Table Global Neuropeptide Y Receptor Sales Market Share Forecast by Product 2018-2025

Table Global Neuropeptide Y Receptor Revenue Forecast by Product 2018-2025 (Million US$)

Table Global Neuropeptide Y Receptor Revenue Market Share Forecast by Product 2018-2025

Table Global Neuropeptide Y Receptor Sales Forecast by End User 2018-2025 (K Units)

Table Global Neuropeptide Y Receptor Sales Market Share Forecast by End User 2018-2025

Figure North America Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)

Figure North America Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Europe Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Europe Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Asia Pacific Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Asia Pacific Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Central & South America Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Central & South America Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Middle East and Africa Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Middle East and Africa Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Forecast of Global Middle-Class Population, 2015 to 2030

Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016

Table Neuropeptide Y Receptor Value Chain

Table Neuropeptide Y Receptor Customers List

Table Neuropeptide Y Receptor Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370